These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22789133)

  • 1. The synthetic futures of vesicular stomatitis virus.
    Overend C; Yuan L; Peccoud J
    Trends Biotechnol; 2012 Oct; 30(10):497-8. PubMed ID: 22789133
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis.
    AuYeung AWK; Mould RC; Stegelmeier AA; van Vloten JP; Karimi K; Woods JP; Petrik JJ; Wood GA; Bridle BW
    Sci Rep; 2021 Jul; 11(1):15290. PubMed ID: 34315959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity.
    van den Pol AN; Davis JN
    J Virol; 2013 Jan; 87(2):1019-34. PubMed ID: 23135719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdoviruses as vectors for vaccines and therapeutics.
    Scher G; Schnell MJ
    Curr Opin Virol; 2020 Oct; 44():169-182. PubMed ID: 33130500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus: re-inventing the bullet.
    Lichty BD; Power AT; Stojdl DF; Bell JC
    Trends Mol Med; 2004 May; 10(5):210-6. PubMed ID: 15121047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.
    Ma Y; Li J
    J Virol; 2011 Mar; 85(6):2942-52. PubMed ID: 21228240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines-all things considered. Part II. 2-3 December 2004, San Francisco, CA, USA.
    Rosenthal KS
    IDrugs; 2005 Feb; 8(2):110-1. PubMed ID: 15696409
    [No Abstract]   [Full Text] [Related]  

  • 10. A focus on vaccination strategies.
    Woodland DL
    Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
    [No Abstract]   [Full Text] [Related]  

  • 11. A tool with many applications: vesicular stomatitis virus in research and medicine.
    Munis AM; Bentley EM; Takeuchi Y
    Expert Opin Biol Ther; 2020 Oct; 20(10):1187-1201. PubMed ID: 32602788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.
    Wollmann G; Drokhlyansky E; Davis JN; Cepko C; van den Pol AN
    J Virol; 2015 Jul; 89(13):6711-24. PubMed ID: 25878115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter from the Editor.
    Ellis R; Weiss A
    Hum Vaccin Immunother; 2015; 11(6):1297. PubMed ID: 26086583
    [No Abstract]   [Full Text] [Related]  

  • 14. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.
    Cooper D; Wright KJ; Calderon PC; Guo M; Nasar F; Johnson JE; Coleman JW; Lee M; Kotash C; Yurgelonis I; Natuk RJ; Hendry RM; Udem SA; Clarke DK
    J Virol; 2008 Jan; 82(1):207-19. PubMed ID: 17942549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular stomatitis virus as a treatment for colorectal cancer.
    Stewart JH; Ahmed M; Northrup SA; Willingham M; Lyles DS
    Cancer Gene Ther; 2011 Dec; 18(12):837-49. PubMed ID: 21886191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lethal mice model of recombinant vesicular stomatitis viruses for EBOV-targeting prophylactic vaccines evaluation.
    Zhang HQ; Zhang ZR; Deng CL; Yuan ZM; Zhang B
    Virol Sin; 2024 Jun; 39(3):516-519. PubMed ID: 38522616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites.
    Ammayappan A; Nace R; Peng KW; Russell SJ
    J Virol; 2013 Mar; 87(6):3217-28. PubMed ID: 23283963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.
    Muik A; Kneiske I; Werbizki M; Wilflingseder D; Giroglou T; Ebert O; Kraft A; Dietrich U; Zimmer G; Momma S; von Laer D
    J Virol; 2011 Jun; 85(11):5679-84. PubMed ID: 21450833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.